PharmaCyte Biotech
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell PMCB and other ETFs, options, and stocks.About PMCB
PharmaCyte Biotech, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of treatments for cancer and diabetes. It focuses on a proprietary cellulose-based live cell encapsulation technology called Cell-in-a-Box, which will be used as a platform for the development of treatments for inoperable pancreatic cancer and other solid cancerous tumors, and diabetes.
CEOJoshua Nathaniel Silverman
CEOJoshua Nathaniel Silverman
Employees2
Employees2
HeadquartersLas Vegas, Nevada
HeadquartersLas Vegas, Nevada
Founded1996
Founded1996
Employees2
Employees2
PMCB Key Statistics
Market cap7.48M
Market cap7.48M
Price-Earnings ratio1.35
Price-Earnings ratio1.35
Dividend yield—
Dividend yield—
Average volume11.27K
Average volume11.27K
High today$1.12
High today$1.12
Low today$1.02
Low today$1.02
Open price$1.05
Open price$1.05
Volume37.31K
Volume37.31K
52 Week high$2.42
52 Week high$2.42
52 Week low$1.00
52 Week low$1.00
People also own
Based on the portfolios of people who own PMCB. This list is generated using Robinhood data, and it’s not a recommendation.